6.04
-0.09(-1.47%)
Currency In USD
| Previous Close | 6.13 |
| Open | 6.41 |
| Day High | 6.41 |
| Day Low | 5.79 |
| 52-Week High | 7.55 |
| 52-Week Low | 2.12 |
| Volume | 2.82M |
| Average Volume | 3.1M |
| Market Cap | 599.81M |
| PE | -8.63 |
| EPS | -0.7 |
| Moving Average 50 Days | 5.88 |
| Moving Average 200 Days | 3.87 |
| Change | -0.09 |
If you invested $1000 in Aquestive Therapeutics, Inc. (AQST) since IPO date, it would be worth $376.32 as of November 08, 2025 at a share price of $6.04. Whereas If you bought $1000 worth of Aquestive Therapeutics, Inc. (AQST) shares 5 years ago, it would be worth $1,086.33 as of November 08, 2025 at a share price of $6.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aquestive Therapeutics Announces Leadership Expansion to Support Growth
GlobeNewswire Inc.
Nov 04, 2025 12:00 PM GMT
Changes strategically aligned to support planned launch of Anaphylm™ (dibutepinephrine) Sublingual Film, if approved by the FDA, and to accelerate the Company’s ongoing development initiatives Matthew Davis, M.D., RPh will join immediately as Chief D
Aquestive Therapeutics to Participate in a Fireside Chat Hosted by Piper Sandler
GlobeNewswire Inc.
Nov 03, 2025 12:00 PM GMT
WARREN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science a
Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting
GlobeNewswire Inc.
Oct 30, 2025 11:00 AM GMT
WARREN, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science a